Matinas Biopharma Holdings, Inc - stock earnings
MTNB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.1 million USD | ? USD |
| 2023Q2 | -6.1 million USD | ? USD |
| 2023Q1 | -5.4 million USD | 1.1 million USD |
| 2022Q4 | -32565 USD | 1.1 million USD |
| 2022Q3 | -5.5 million USD | 1.1 million USD |
| 2022Q2 | -5.9 million USD | 1.1 million USD |
| 2022Q1 | -2.5 million USD | ? USD |
| 2021Q4 | -6.7 million USD | -33300 USD |
| 2021Q3 | -6.8 million USD | ? USD |
| 2021Q2 | -4.8 million USD | ? USD |
| 2021Q1 | -5.0 million USD | 33333 USD |
| 2020Q4 | -6.3 million USD | 62500 USD |
| 2020Q3 | -5.4 million USD | 95833 USD |
| 2020Q2 | -5.6 million USD | ? USD |
| 2020Q1 | -5.0 million USD | ? USD |
| 2019Q4 | -5.6 million USD | -89812 USD |
| 2019Q3 | -4.4 million USD | ? USD |
| 2019Q2 | -3.3 million USD | 89812 USD |
| 2019Q1 | -3.6 million USD | -119750 USD |
| 2018Q4 | -3.6 million USD | 119750 USD |
| 2018Q3 | -2.9 million USD | 89813 USD |
| 2018Q2 | -3.4 million USD | 89813 USD |
| 2018Q1 | -4.1 million USD | 29937 USD |
| 2017Q4 | -3.6 million USD | 44906 USD |
| 2017Q3 | -3.4 million USD | 44906 USD |
| 2017Q2 | -4.0 million USD | 44906 USD |
| 2017Q1 | -4.5 million USD | 14969 USD |
| 2016Q4 | -1.9 million USD | 2.3 million USD |
| 2016Q3 | -1.8 million USD | ? USD |
| 2016Q2 | -1.6 million USD | ? USD |
| 2016Q1 | -2.2 million USD | ? USD |
| 2015Q4 | -2.0 million USD | -194494 USD |
| 2015Q3 | -2.2 million USD | 59858 USD |
| 2015Q2 | -2.4 million USD | 77000 USD |
| 2015Q1 | -2.6 million USD | 57636 USD |
| 2014Q4 | -3.0 million USD | ? USD |
| 2014Q3 | -2.6 million USD | ? USD |
| 2014Q2 | -2.4 million USD | ? USD |
| 2014Q1 | -2.1 million USD | ? USD |
| 2013Q4 | -1.8 million USD | ? USD |
| 2013Q3 | -1.5 million USD | ? USD |
| 2013Q2 | -343314 USD | ? USD |
| 2013Q1 | -112133 USD | ? USD |
MTNB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.3 million USD | 2.2 million USD |
| 2022 | -13.0 million USD | 3.2 million USD |
| 2021 | -21.2 million USD | 33333 USD |
| 2020 | -20.6 million USD | 158333 USD |
| 2019 | -15.6 million USD | 90000 USD |
| 2018 | -14.1 million USD | 119750 USD |
| 2017 | -15.5 million USD | 149687 USD |
| 2016 | -7.6 million USD | ? USD |
| 2015 | -9.1 million USD | 194494 USD |
| 2014 | -10.2 million USD | ? USD |
| 2013 | -3.7 million USD | ? USD |
MTNB
Price: $0.17
52 week price:
Earnings Per Share: -0.11 USD
P/E Ratio: -2.08
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 237100
Market Capitalization: 51.0 million